2m 2m 2m 2m 2m 2m 2m
GRI Bio (GRI)
NASDAQ
$1.86-$0.04 (-2.37%)
Price as of Sep 11, 2026 7:42 PM EDT- $4.2MMarket Cap
- -96.25%1-Year Change
- BiotechnologyIndustry
GRI Bio (GRI)
$1.86-$0.04 (-2.37%)
GRI | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.90 | ||
Change | -$0.04 (-2.06%) | ||
Open | $1.99 | ||
High | $2.05 | ||
Low | $1.85 | ||
Previous Close | $1.94 | ||
Volume | 131,906 | ||
30-Day Average Volume | 548,269 | ||
1-Week Change | -34.03% | ||
1-Month Change | -13.64% | ||
1-Year Change | -96.25% | ||
3-Year Change | -100.00% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 2.2M | ||
Total Assets | $11.4M | ||
Market Cap | $4.2M | ||
Enterprise Value | -$6.8M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$1.6M | ||
Free Cash Flow | -$1.4M | ||
EBIT | -$1.6M | ||
EBITDA | -$1.6M | ||
Net Working Capital | $10.2M | ||
EPS | -$0.91 | ||
Enterprise Value/EBITDA | 4 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 0 | ||
P/E | -2 | ||
PEG | -0 | ||
Price/Free Cash Flow | -3 | ||
Price/Operating Cash Flow | -3 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 12/19/2019 | ||
Last Split Factor | 1 : 28 | ||
Last Split Date | 01/26/2026 | ||
Earnings & Revenue